While GPS2 acts largely anti-inflammatory by inhibiting M1-type metabolic inflammation under conditions of obesity and diabetes (20,36,37), it might act rather pro-inflammatory in a M2-type micro-environment, for example in macrophages involved in wound healing (6) or in tumor-associated macrophages involved in metastasis (9). The gene discussed is GPS2; the disease is obesity disorder.